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phenotypic and functional 
characterization of corneal 
endothelial cells during in vitro 
expansion
Ricardo f. frausto1, Vinay S. Swamy1, Gary S. L. peh2, payton M. Boere1, e. Maryam Hanser1, 
Doug. D. chung1, Benjamin L. George2, Marco Morselli3,4, Liyo Kao5, Rustam Azimov5, 
Jessica Wu1, Matteo pellegrini3,4,6,7, ira Kurtz5,8, Jodhbir S. Mehta2 & Anthony J. Aldave1 ✉
the advent of cell culture-based methods for the establishment and expansion of human corneal 
endothelial cells (CEnC) has provided a source of transplantable corneal endothelium, with a significant 
potential to challenge the one donor-one recipient paradigm. However, concerns over cell identity 
remain, and a comprehensive characterization of the cultured cenc across serial passages has not 
been performed. to this end, we compared two established cenc culture methods by assessing the 
transcriptomic changes that occur during in vitro expansion. In confluent monolayers, low mitogenic 
culture conditions preserved corneal endothelial cell state identity better than culture in high mitogenic 
conditions. expansion by continuous passaging induced replicative cell senescence. transcriptomic 
analysis of the senescent phenotype identified a cell senescence signature distinct for CEnC. We 
identified activation of both classic and new cell signaling pathways that may be targeted to prevent 
senescence, a significant barrier to realizing the potential clinical utility of in vitro expansion.
The corneal endothelium is a neuroectoderm-derived tissue that is located on the posterior surface of the cornea 
and is a semipermeable monolayer of mitotically inactive (i.e., quiescent) cells. A critical functional property of 
the corneal endothelium is to maintain the corneal stroma in a relatively dehydrated state. This process ensures 
that the collagen fibers of the stroma retain an ultrastructural organization essential for corneal transparency. The 
pump-leak hypothesis is believed to best explain the role that the endothelium plays in maintaining a relatively 
dehydrated stroma. Passive movement of water from the aqueous humor to the stroma (i.e., leak) and active 
transport of solutes (i.e., pump) in the opposite direction are regulated by the corneal endothelial cell (CEnC) 
barrier formation (i.e., tight junctions, cell adhesion) and expression of solute transporters (e.g., Na/K ATPases, 
SLC4A11)1. Mutations in genes encoding solute transporters (e.g., SLC4A11) or other essential endothelial cell 
functions (e.g., ZEB1, TCF4) lead to stromal edema and loss of corneal clarity2–5. In general, loss of barrier integ-
rity, dysfunction of solute transporters or a significant decrease in CEnC density leads to the loss of corneal clarity 
that necessitates corneal transplantation. Endothelial cell failure constitutes the primary indication for corneal 
transplantation both worldwide and in the U.S., serving as the indication for 55% of all keratoplasty procedures 
performed in the US in 20186. While endothelial keratoplasty represents a significant advance in the surgical 
management of corneal endothelial dysfunction, a variety of associated intraoperative and postoperative compli-
cations, in addition to the low rates of donor corneal recovery and the lack of adequately trained surgeons in the 
majority of countries, have significantly limited the impact of endothelial keratoplasty on visual impairment due 
to corneal endothelial dysfunction worldwide7–9.
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The worldwide shortage of donor corneal tissue for the treatment of corneal endothelial dysfunction necessi-
tates the development of viable alternatives to the paradigm of one donor cornea being used for only one recipi-
ent10–12. The in vitro generation of stem cell-derived corneal endothelial-like cells13, immortalized CEnC lines14,15 
and expansion of primary CEnC from cadaveric donor corneal tissue10,16,17 have challenged the one donor-one 
recipient paradigm of corneal transplantation. Nevertheless, in vitro culture poses its own challenges, including 
unwanted changes in cell phenotype (e.g., endothelial to fibroblastic) and progression towards replicative senes-
cence that limits cell numbers11,18. In addition, the quality of the donor tissue from which the CEnC are derived is 
critical in the successful establishment of an in vitro CEnC culture. Donor age significantly impacts culture suc-
cess rate, with the optimal age being less than 40 years old. Reduced success rates from older donors are correlated 
with an appearance of senescence-associated markers ex vivo19, and this is believed to significantly limit re-entry 
into the cell cycle even in the presence of potent mitogenic factors. While senescence is generally an irreversible 
cell state20, CEnC from younger donors are characterized by a quiescent cell state (G1 cell cycle arrest), which is 
a reversible mitotic arrest that enables these cells to undergo mitogen-induced cell cycle re-entry21. Donor age 
and other factors (e.g., days in preservation medium, donor medical history, cell count) dictate the success of 
establishing in vitro cultures11. This makes identifying an optimal in vitro culture protocol essential for ensuring 
consistent establishment and expansion of CEnC.
To achieve this goal, we assessed two previously reported methods for establishing cultures of primary CEnC, 
one with a relatively high mitogenic environment and the other with reduced mitogenic conditions22,23 by using 
a multipronged approach. CEnC require dissociation and growth in mitogen-rich medium to overcome mitotic 
block and to initiate cell division24. However, prolonged exposure to mitogen-rich conditions leads to a fibroblas-
tic phenotype. Change to a low mitogenic environment facilitates re-establishment/maintenance of the contact 
inhibited quiescent CEnC phenotype22,25. Because the mitogen-rich approach is the classic method for in vitro 
expansion of CEnC, we chose to compare it to the recently described “dual media” approach. We determined the 
impact of in vitro expansion on CEnC gene expression by performing a transcriptomics analysis, and identified 
gene expression features of replicative senescence. In addition, we performed a variety of assays to determine the 
impact of these two methods on essential CEnC functions. We identified new potential targets for suppressing 
cellular senescence, and confirmed that a relatively low mitogenic environment is better at maintaining the CEnC 
phenotype in vitro22. These findings form the basis for continued development of in vitro culture and expansion 
of primary CEnC for their eventual use in cell replacement therapy for the management of corneal endothelial 
loss or dysfunction.
Results
In vitro expansion of cenc induces senescence-associated morphogenesis. The morphogenic 
effects of culture in high mitogenic (F99) and low mitogenic (M5) conditions on primary CEnC were exam-
ined (Fig. 1). Phase contrast images were acquired at each passage when confluent monolayers were established 
(Fig. 1B and Supplementary Fig. S1). Morphometric analysis was performed at each passage (Fig. 1C). Up to 
passage 3, the area occupied by each cell was greater in F99, compared with cells in M5, but the effect of medium 
on the curves was not statistically significant (p = 0.065). Cell circularity, which measures the degree to which a 
cell shape resembles a circle (1.0 is a perfect circle), was greater at all passages for cells in M5 medium, compared 
with cells in F99. The effect of medium on the curves for circularity was statistically significant (p = 0.042). As the 
value approaches 0, cell shape is increasingly irregular and/or elongated.
A low mitogenic environment maintains a robust CEnC-specific gene expression profile in pri-
mary cenc. To examine the ability of the cultured cells to maintain a CEnC-specific gene expression profile 
in low- or high-mitogenic environments, we compared the expression of 97 genes, previously identified as specific 
to ex vivo corneal endothelium (evCEnC), in primary CEnC in M5 versus F99 at each passage (Fig. 2)26. At P0, 
the cells in M5 expressed 83 of the 97 (85.6%) evCEnC-specific genes, while cells in F99 expressed 76 (78.4%) 
(Fig. 2A). By P4, the percentages decreased to 75.3% (73/97) in cells cultured in M5, and 66% (64/97) in cells 
cultured in F99 (Fig. 2A). We examined the 97 evCEnC-specific genes in the passaged cells to identify those that 
may be suitable positive selection markers for assessing the quality of CEnC cultures using the following criteria: 
1) expression in 2 or more sequential passages, starting with P0; 2) decreasing expression over increasing passages 
(Fig. 2B); and 3) encoding a cell surface protein. Only TMEM178A demonstrated these characteristics (Fig. 2C), 
and its expression was validated by qPCR at P0 and P3 (Fig. 2D).
An analysis of the expression of genes purported to be markers for CEnC identity and/or to determine the 
quality of CEnC in culture revealed that many were neither specific nor highly expressed in corneal endothe-
lium (e.g., ATP1A1, TJP1, VIM, PRDX6, SLC3A2), or did not correlate well with other quality metrics, such as 
cell morphology (e.g., ALCAM1, ERBB2, CD248, SLC25A11) (Supplementary Fig. S2). We should note that our 
data represents transcript abundance, and these markers may prove to be adequate based on protein abundance, 
which was not determined for the majority of the reported markers in this study. Based on transcript abun-
dance, SLC4A11 and CD44 may represent the optimal markers for selection of high quality cultured CEnC, with 
SLC4A11 classified as a positive selection marker and CD44 classified as a negative selection marker (Fig. 3). 
SLC4A11 and CD44 transcript abundances at P0 and P3 in CEnC cultured in both F99 and M5 was determined 
by RNA-seq and validated by both qPCR and a Western assay (Fig. 3A). Expression of SLC4A11, which was high 
in evCEnC, decreased with increasing passage, while expression of CD44, which was high in evCEpC, increased 
with increasing passage (Fig. 3B).
Low mitogenic conditions establish a robust functional barrier in cenc. To determine the impact of 
cell culture conditions on the establishment of a functional barrier, we measured resistance of the CEnC to an elec-
trical current (Fig. 4). Initially, we measured barrier function of cells isolated/grown using unmodified protocols for 
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each of the two methods employed in this study (Tryp-LN-F99 and ColA-ColIV-M4M5). CEnC cultured using the 
ColA-ColIV-M4M5 method demonstrated markedly greater impedance compared with CEnC cultured using the 
Tryp-LN-F99 method (Fig. 4A). Impedance data was then used to model cell-cell (Rb) and cell-substrate (α) inter-
actions, which demonstrated that both contribute to the greater barrier function observed in cells cultured using the 
ColA-ColIV-M4M5 method. To identify a potential effect of the dissociation enzymes (trypsin and collagenase A) 
on the establishment of a functional barrier, we modified the isolation/growth protocols to exchange one enzyme for 
the other. Exchanging the enzymes did not have a marked effect on the establishment of a functional barrier, with the 
cells cultured using the protocol containing ColIV-M4M5 establishing a more robust functional barrier compared 
with cultures established with the protocol containing LN-F99 (Fig. 4B). To determine the contribution, if any, of the 
substrate (laminin or collagen) to which the cells adhere, or of the media (F99 or M5) in which the cells are cultured, 
we exchanged the substrates for each other and used F99 and M5 for each (Fig. 4C). Due to the limitation in the 
number of replicates we could assay, we chose trypsin (Tryp) as the dissociation enzyme, since use of either trypsin 
or collagenase A did not make a significant difference on establishment of a functional barrier. While only marginal 
differences in the electrical impedance were observed up to approximately 48 hours between Tryp-LN-M4M5 and 
Tryp-ColIV-M4M5, after that time point the cells that were cultured using the Tryp-LN-M4M5 method demonstrated 
a progressively weakening barrier. Additionally, the cells that were cultured using the Tryp-LN-M4M5 method demon-
strated a marked decrease in cell-cell and cell-substrate adhesion after 48 hours. We observed a markedly weaker barrier 
Figure 1. M5 medium delays morphologic features associated with a senescent phenotype. (A) Protocols for 
the isolation and culture of primary CEnC in high (F99) and low (M5) mitogenic conditions were compared. 
Images show cells 1-day after seeding (right panel). (B) Images show confluent CEnC cultures at five passages 
using two culture methods (F99 or M5). (C) Line graph shows mean cell area (μm) at each passage. (D) Line 
graph shows mean circularity at each passage. Data in (C,D) are represented as the mean ± SEM (n = 6). 
Statistical comparisons were performed using two-way ANOVA, with passage and medium defining the 
variables for this comparison. Scale bars, 100 μm.
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for cells cultured in F99 (Tryp-LN-F99 or Tryp-ColIV-F99) compared with Tryp-ColIV-M4M5 for the entire duration 
of the experiment.  
To determine whether the differences observed in barrier function between the two culturing methods (F99 
versus M5) could be explained by differences in barrier-associated proteins or in the organization of the adhesive 
interactions between cells, we examined the expression and localization of the cadherin protein CDH2. While 
CDH2 transcript levels measured by qPCR were significantly (p < 0.01) lower in cells cultured in M5, the CDH2 
protein levels were not different (Fig. 4D). However, the organization of the adhesive interaction between cells 
was markedly different between cells grown in F99 and M5 (Fig. 4E). In F99, the cell-cell interactions appeared 
diffuse and frayed, although these features were not consistent for all cell-cell interactions, and lacked features of 
a well-formed lateral membrane. In contrast, the cells grown in M5 appeared to have consistent cell-cell interac-
tions with what appears as prominent lateral membranes, which give the image the impression of depth.
A strong functional barrier in primary cenc is associated with robust expression of adhesion 
and glycocalyx proteins. To determine the extent to which barrier-associated proteins may be involved in 
the more robust establishment of a functional barrier of CEnC in M5 media, we examined several proteins associ-
ated with either cell-cell adhesion or glycocalyx formation (Fig. 5). We first measured the expression of genes that 
encode adhesion-associated proteins (CLDN11, AJAP1, TMEM204 and TMEM178A), and quantified protein 
levels for each (Fig. 5A). The expression of each of the four genes was higher in CEnC cultured in M5 compared to 
F99, reaching statistical significance (p < 0.05) for all four when measured at the transcript level by qPCR, and for 
two (CLDN11 and TMEM178A) when measured at the protein level (p < 0.01). We then measured the expression 
of genes that encode glycocalyx-associated proteins (APOE, MYOC, DCN, LUM and APOD), and quantified 
protein levels for each (Fig. 5B). Significantly (p < 0.05) higher transcript levels were observed for all five genes in 
CEnC cultured in M5, but only two of the proteins (MYOC and APOD) demonstrated significantly higher levels. 
The APOE (p = 0.05) and LUM (p = 0.14) proteins were markedly higher in M5, but did not achieve statistical 
Figure 2. M5 medium maintains CEnC-specific gene expression in cultured CEnC. (A) Line graph shows 
the number of evCEnC-specific genes expressed in CEnC cultured in either F99 or M5 medium. Dashed 
line represents the number (97) of evCEnC-specific genes identified in a previous study. (B) Venn diagrams 
demonstrating the expression of evCEnC-specific genes at passages P0-P3 (P4 not shown due to difficulty 
visualizing Venn diagrams of greater than 5 sets). TMEM178A was identified as a cell surface marker expressed 
in early passages (at least P0 and P1) in CEnC cultured in either F99 or M5. (C) Line graphs show expression 
pattern of TMEM178A in CEnC cultured in F99 or M5. Gene was considered expressed if TPM value was 
greater than 7.5 (dashed line). (D) Bar graph shows TMEM178A transcript abundances in P0 and P3 CEnC 
using qPCR. Data in (D) are represented as the mean ± SEM (n = 4). Statistical comparisons were performed 
using one-way ANOVA with post-hoc Tukey test. **P < 0.01.
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significance. DCN did not demonstrate a difference in protein levels between the two media. Of note, APOD 
is known to exist in three forms (pre-modified, post-modified, and complexed), each of progressively greater 
molecular weight, all of which demonstrated significantly (p < 0.05) higher expression in M5 compared with F99.
Robust cenc pump function is established by culture in low mitogenic conditions. The SLC4A4, 
SLC4A11 and SLC16A1 transporters are highly expressed in in vivo corneal endothelium, and play a promi-
nent role in maintaining the solute gradients necessary for regulation of water transport from the stroma to the 
anterior chamber. To determine the level of expression and functional capacity of each in F99 and M5 media, 
we measured transcript levels by RNA-seq and qPCR, protein levels by Western, and transporter activity with a 
fluorescence-based transporter assay (Fig. 6). SLC4A11 demonstrated significantly higher (p < 0.01) and SLC4A4 
demonstrated non-significantly (p = 0.081) higher transcript levels in M5 medium, while the proteins encoded by 
all three genes demonstrated significantly (p < 0.05) higher levels in M5 compared with F99 (Fig. 6A).
To assess transporter function, we assayed for intracellular proton concentration (i.e., pHi) over time, includ-
ing after changes in buffer perfusion, since each of the transporters transfer protons across the plasma mem-
brane (Fig. 6B). Traces showing intracellular pH demonstrate sensitivity to buffer changes for each transporter. 
Qualitatively, the rate of change in intracellular proton concentration mediated by SLC4A4 and SLC4A11 fol-
lowing a change in buffer appears greater in M5 compared with F99 medium. In contrast, the rate of change in 
intracellular proton concentration mediated by SLC16A1 following a change in buffer appears greater in F99 
compared with M5 medium. Quantitatively, and as an indirect measure of transporter activity, we calculated the 
change in intracellular proton concentration over time (d[Hi]/dt) for each of the assays, and observed significantly 
(p < 0.01) higher SLC4A4 and SLC4A11 and significantly (p < 0.01) lower activity for SLC16A1 for cells cultured 
in M5.
Low mitogenic conditions cause decreased cell migration capacity. We measured cell migration 
using a non-wounding method (Fig. 7). Phase contrast imaging of cell migration demonstrated significantly 
(p < 0.001) less gap closure for CEnC in M5 compared with F99 medium (Fig. 7A,B). We observed that cells 
cultured in M5, while possessing lower migration capacity, also appear to markedly cover the gap primarily by 
Figure 3. SLC4A11 and CD44 as cell surface markers for the selection of high quality cultured CEnC. 
Assessment of previously published markers and results obtained in this study provide evidence that SLC4A11 
and CD44 represent the most informative markers for the selection of high quality cultured cells, and represent 
a minimum for selection. (A) Bar graphs show transcript (RNA-seq and qPCR) abundance of SLC4A11 and 
CD44 in P0 and P3 CEnC cultured in F99 and M5. Detection and quantification of SLC4A11 and CD44 was 
performed using a Western assay (Wes). Bar graphs show protein quantification. (B) Line graphs show SLC4A11 
and CD44 transcript quantities in CEnC at each passage (P0–P4). Bar graphs show transcript abundance in 
the three main cell types of the cornea ((epithelial cells (evCEpC), keratocytes (evK) and endothelial cells 
(evCEnC)). Data in bar graphs in (A) are represented as the mean ± SEM (n = 7, RNA-seq; n = 4, qPCR; n = 3, 
Wes). Data in line graphs are represented as the mean TPM at each passage (n = 7). Data in bar graphs in (B) are 
represented as the mean TPM, ± SEM (n = 3). Statistical comparisons were performed using one-way ANOVA 
with post-hoc Tukey test. *P < 0.05; ***P < 0.001.
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Figure 4. Cultured CEnC establish and maintain robust barrier function in M5 medium. (A) Line graph 
shows electrical impedance (Ω at 4000 Hz) for P0 CEnC monolayers established in F99 and M5 media. The 
contribution of cell-cell adhesion to the resistance of electrical current was modeled from impedance data 
and given as Rb (Ω • cm2). The contribution of cell-substrate adhesion to resistance of electrical current was 
modeled from impedance data and given as (α, Ω1/2 • cm). (B) Line graph shows electrical impedance for 
CEnC monolayers established from cells dissociated with trypsin (Tryp) or collagenase (ColA), and each 
cultured in F99 and M5 medium. The contribution of cell-cell (Rb) and cell-substrate (α) to electrical resistance 
were modeled from the impedance data. (C) Line graph shows electrical impedance for CEnC monolayers 
established from cells dissociated with trypsin (Tryp), seeded on either laminin (LN) or collagen (ColIV), and 
cultured in either F99 and M5 medium. The contribution of cell-cell (Rb) and cell-substrate (α) to electrical 
resistance was modeled from the impedance data. (D) Bar graphs show abundance of CDH2, a contributor 
to cell-cell adhesion, in CEnC cultured in F99 and M5 (top panel). Western results for CDH2 protein and 
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increasing the cell size rather than by migration (Fig. 7C). We calculated the ratio of the area occupied by the cells 
that “migrated” into the gap versus cells more distant from the gap, and which have not substantially changed 
their size compared with prior to when migration was initiated (Fig. 7D). Cell size for cells cultured in M5 and 
occupying any portion of the gap cover a significantly (p < 0.05) larger area compared with cells cultured in F99.
cenc grown in a low-mitogenic environment possess a robust cellular respiration pheno-
type. We performed bioinformatics analyses using differentially expressed genes to determine the biological 
characteristics of cells cultured with F99 and M5. We identified the genes that were significantly differentially 
expressed in cells at each passage between the two growth conditions (Supplementary Table S1). With progressive 
passaging, the number of genes showing differential expression (M5 compared to F99 at each passage) decreased 
for cells in each media condition, with the transcriptomes of the cells grown in F99 and cells grown in M5 becoming 
increasingly more similar (Supplementary Fig. S3). As the gene expression difference was greatest at P0 (between F99 
and M5), we performed bioinformatics analyses on the data set obtained at P0. The genes upregulated in cells with 
each media at P0 were subsequently analyzed to identify gene ontology (GO) and pathway terms enriched in our 
data sets (Supplementary Table S2). GO terms significantly (q-value < 0.05) enriched in the F99 (P0) upregulated 
genes data set were associated with cell differentiation and tissue development (e.g., developmental process, system 
development, and multicellular organism development) (Table 1). In addition, significantly enriched pathway terms 
were associated with cell state transitions (e.g., TGF-beta signaling pathway and epithelial to mesenchymal transi-
tion in colorectal cancer) and cell senescence (e.g., senescence and autophagy in cancer). The significantly enriched 
GO terms in the M5 (P0) upregulated genes data set were associated with cellular respiration (e.g., oxidoreductase 
activity and electron transfer activity) and lipid metabolism (e.g., lipid oxidation and fatty acid oxidation). Similarly, 
pathway terms enriched in this data set were also associated with cellular respiration (e.g., electron transport chain 
(OXPHOS system in mitochondria)) and lipid metabolism (e.g., fatty acid metabolism). GO and pathway enrich-
ment results were similar for the other passages within the same media group (Supplementary Table S2).
Senescence of primary cenc is not dependent on mitogen concentration. To determine whether 
the observed senescent-associated morphogenic changes coincide with gene expression changes, we assessed the 
expression changes for genes previously associated with cell senescence (Supplementary Table S3). Many of these 
genes demonstrated marked expression changes and trends in expression that are consistent with the senescent 
phenotype observed for many distinct cell systems. To determine the functional consequences of changes in 
gene expression, we identified genes that were significantly differentially expressed at each passage (P0 was the 
reference), and for each medium (Supplementary Table S4). Passage 3 and 4 showed the greatest number of differ-
entially expressed genes (Supplementary Fig. S3), which coincided with marked changes in morphometric meas-
ures. We subsequently performed GO and pathway analysis to determine the GO and pathway terms enriched 
in this data set (Supplementary Table S5). GO terms significantly (q-value < 0.05) enriched in the F99 (P3 and 
P4) differentially expressed genes data set were associated with cell senescence-associated GO terms (e.g., mitotic 
cell cycle, response to stress and MAPK cascade), and enriched pathway terms were also associated with senes-
cence (e.g., p53 signaling pathway and cellular senescence) (Table 2). Similarly, the significantly enriched GO and 
pathway terms in the M5 (P3 and P4) differentially expressed genes data set were also associated with cellular 
senescence, but showed significant enrichment for pathway terms associated with cellular energy processing (e.g., 
oxidative phosphorylation and the citric acid (TCA) cycle and respiratory electron transport).
The gene ontology and pathway analyses described above identified biological features in CEnC as a conse-
quence of differentially expressed genes. However, these analyses are performed in the absence of the known 
direction of differential expression (i.e., downregulated and upregulated) for each gene. To utilize the direction 
of differential gene expression for the purpose of informing not only pathway enrichment, but also pathway 
activation state, we used the Ingenuity Pathway Analysis software (Supplementary Table S6). Significantly acti-
vated (z-score > 1) pathways in all (P3 (F99 and M5) and P4 (F99 and M5)) data sets were associated with an 
immune-like response (Table 3). Significantly deactivated (z-score < −1.0) pathways for all data sets were gener-
ally associated with metabolic pathways, which included pathways associated with lipid metabolism, nucleotide 
biosynthesis, glycolysis and cellular respiration.
Cell senescence is characterized by an irreversible cell cycle arrest. To determine the impact of passaging (i.e., 
expansion) on the cell cycle, we examined the intra-media data sets by focusing on the predicted activation state 
(as predicted by IPA software) of cell cycle functions (Supplementary Table S7). Generally, this analysis demon-
strated activation (z-score > 0.5) of cell senescence-associated functions (e.g., senescence of cells) and deactiva-
tion (z-score < −1.0) of cell cycle functions that have a positive effect on the cell cycle (e.g., mitosis and cell and 
cell cycle progression) (Table 4).
Senescence of primary CEnC involves the activation of the p53 and p38-MAPK pathways. To 
determine whether senescence of primary CEnC involves activation of the p53 and p38-MAPK pathways and 
regulation of the cell cycle, we examined expression and activation of genes/proteins known to regulate cell cycle 
arrest due to senescence (Fig. 8). Expression of the genes that encode p53 (TP53) or p38-MAPK (MAPK14) was 
bar graph shows protein quantification (bottom panel). TUBA was used as a loading control in the Western. 
(E) Immunofluorescence results show localization of CDH2 protein in CEnC cultured in F99 and M5. Red, 
Alexafluor 594; blue, DAPI. Data in line graphs are represented as the mean ± SD (n = 4), and data in bar 
graphs are represented as the mean ± SEM (n = 7, RNA-seq; n = 4, qPCR; n = 3, Wes). Statistical comparisons 
were performed using an unpaired t-test. *P < 0.05; **P < 0.01.
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Figure 5. M5 medium increases the expression of barrier-associated genes and proteins. (A) Bar graphs show 
the expression levels (RNA-seq and qPCR) of genes associated with cell adhesion (CLDN11, AJAP1, TMEM204 
and TMEM178A) in P0 CEnC. Detection and quantification of the proteins encoded by these genes were 
performed using a Western assay (Wes). (B) Bar graphs show the expression levels (RNA-seq and qPCR) of 
genes associated with the glycocalyx (APOE, MYOC, DCN, LUM and APOD). Detection and quantification of 
the proteins encoded by these genes were performed using a Western assay (Wes). Three forms of APOD were 
observed, and each was quantified and graphed. The protein forms observed were a pre-modified form (1), a 
post-modified form (2) and a high molecular weight complex form (3). TUBA was used as a loading control 
in the Westerns. Data in bar graphs are represented as the mean ± SEM (n = 7, RNA-seq; n = 4, qPCR; n = 3, 
Wes). Statistical comparisons were performed using an unpaired t-test. *P < 0.05; **P < 0.01; ***P < 0.001; 
****P < 0.0001.
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not markedly different between P0 and P3 CEnC. Phosphorylation of p53 and p38-MAPK is a hallmark of cel-
lular senescence in many cell types and tissues, and using Western analysis we detected phosphorylation of both 
proteins at P3 in both low and high mitogenic conditions, compared with phosphorylation at P0 (p < 0.05). In 
addition, significant (p < 0.05) differential gene expression of the senescence markers LMNB1, GADD45A and 
CD44 was observed at P3 in either F99 or M5 or both, a result consistent with cell senescence (Fig. 8B; see Fig. 3A 
for CD44 expression). We also observed significantly increased expression of the CD44 protein at P3, which was 
consistent with CD44 transcript levels (Fig. 3A).
The cell cycle includes various phases (G1, S, G2 and M) that involve cyclin and cyclin-dependent kinases 
(CDK) (Fig. 8C). In the absence of inhibitors of the CDK, cell cycle progression is dependent on the availability 
and interaction of cyclins and CDK. However, two classes of inhibitors, INK4 and KIP/CIP, are able to inhibit 
cell cycle progression via interaction of the cyclin-dependent kinase inhibitors p21CIP1 (CDKN1A) and p16INK4 
(CDKN2A) with the cyclin/CDK complexes, an interaction that ultimately blocks the complexes’ downstream 
actions and results in cell cycle arrest. While transcript quantification demonstrated a significant increase in 
gene expression in P3 cells only for CDKN2A, the expression of the encoded proteins were either significantly 
(p < 0.05; CDKN1A, CDK4) or markedly (CDKN2A, CDK4 and CDK6) increased in P3 cells cultured in F99 
and M5 (Fig. 8D,E). Marked increases in protein expression of both p21CIP1 (CDKN1A) and p16INK4 (CDKN2A), 
which are upregulated in senescent cells, were observed in P3 CEnC cultured in F99 or M5 (Fig. 8D). In addition, 
accumulation of CDK4 and CDK6, CDK important in progression through G1/S of the cell cycle, was observed 
in P3 cells cultured in F99 and M5 (Fig. 8E). As an increase in cyclin D, in conjunction with increases in p16INK 
(CDKN2A), CDK4 and CDK6, is a hallmark of G1 cell cycle arrest, we measured the expression of the four cyclins 
(cyclins A, B, D and E). A marked and progressive increase in cyclin D was observed in cells cultured in both 
F99 and M5, in contrast to the expression of the other three cyclins, which was unchanged through P4 (Fig. 8F).
Discussion
Corneal clarity depends on the corneal endothelium, and disease or injury to this tissue causes loss of visual 
acuity that may necessitate corneal transplantation. The development and widespread adoption of endothelial 
keratoplasty techniques has significantly improved outcomes of the surgical management of corneal endothelial 
cell dysfunction although postoperative complications remain7–9. However, the current paradigm of one donor 
Figure 6. SLC4A4 and SLC4A11 transporter activity is increased in M5 medium. (A) Bar graphs show 
transcript abundances (RNA-seq and qPCR) in P0 CEnC for genes that encode membrane bound transporters 
(SLC4A4, SLC4A11 and SLC16A1). Detection and quantification of the encoded proteins was performed 
using a Western assay (Wes). (B) Traces show change in pH levels before and after perfusion with buffer 
containing indicated substrate specified for the transporter (SLC4A4, Na+; SLC4A11, H+; SLC16A1, lactate). 
Arrows indicate time at which buffer was changed. Bar graphs show the rate of change in intracellular proton 
concentration [Hi], which was calculated as a proxy for transporter activity. Data in bar graphs are represented 
as the mean ± SEM (n = 7, RNA-seq; n = 4, qPCR; n = 3, Wes; n = 6, transporter activity). Statistical 
comparisons were performed using the unpaired t-test. *P < 0.05; **P < 0.01; ****P < 0.0001.
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cornea for one recipient requires cornea donation, recovery and utilization rates that are present in only a few 
countries in the world that are able to meet the domestic need for transplantable corneas. Based on data obtained 
between August 2012 and August 2013, an estimated 12.7 million people were waiting for a corneal transplant, 
with only 1 cornea available for every 70 needed27. Thus, in an effort to achieve sufficient cell numbers of trans-
plantable high quality CEnC to challenge the one donor-one recipient paradigm, scientists and clinicians have 
developed various methods for the isolation and in vitro culturing of CEnC11. The purpose of this study was to 
compare the cell profiles of cultured CEnC between two established culturing protocols across serial passages by 
using several metrics to assess the identity (e.g., morphology, biomarker expression) and function (e.g., transcel-
lular resistance, intracellular proton concentration) of cultured CEnC. However, due to the scope and limitations 
of this study, future additional functional studies to validate our findings and a comprehensive investigation of 
the effects of in vitro expansion on the CEnC transcriptome are still needed. Keeping the scope and limitations of 
this study in mind, the transcriptomic work performed as part of this study may be used as one of the criteria for 
assessing the quality and viability of in vitro expanded CEnC for use in cell-replacement therapy. In particular, 
because cell senescence is a feature of primary cell culture, it is necessary to identify the potential signaling and 
metabolic pathways involved in CEnC senescence prior to developing strategies to target these pathways and 
delay senescence, thereby producing a larger number of therapeutically suitable cells.
In 1978, the first human CEnC cultures were described, but given a lack of human-specific protocols, the 
researchers used culture conditions optimized for growth of rabbit CEnC28. Over the next decade, techniques 
for the isolation of human CEnC and growth media for the in vitro culture of human CEnC were optimized. In 
1989, Engelmann et al. determined that a 1:1 mixture of M199 and F12 media was the optimal base medium 
for culture of primary CEnC29. Two decades later, the formulation of the medium was modified to induce cell 
cycle re-entry (due to relatively mitogen-rich conditions) and establishment of contact inhibition, leading to 
quiescence, a non-proliferative cell state that characterize CEnC in vivo15. We started culturing primary CEnC 
Figure 7. CEnC cultured in M5 medium possess attenuated migration capacity. (A) Phase contrast images 
show initial gap (0 hours) and gap closure (22 hours) of P0 CEnC cultured in F99 and M5. (B) Bar graph shows 
quantification of gap closure at 22 hours as a percent of the initial gap. (C) Phase contrast images show gap 
closure at 60 hours. (D) Bar graph shows the ratio of the mean area at 60 hours of the cells near or populating 
the gap divided by the mean area of the cells not near the gap. Data in bar graphs are represented as the mean 
± SEM (n = 4). Statistical comparisons were performed using one-way ANOVA with post-hoc Tukey test. 
*P < 0.05; ***P < 0.001. Scale bars, 100 μm.
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in 2011, and chose the medium formulation described by Valtink et al. as it was at the time the most effective 
formulation for the culture of both primary and immortalized CEnC. Nevertheless, about 40% (3/7 at P0 in this 
study) of the cultures we established did not possess CEnC-like morphology, and were generally characterized by 
a mixture of morphologies (some resembling fibroblasts), an observation consistent with previous findings by the 
developers of the formulation (R. Faragher, personal communication, March 2017). In 2015, Peh et al. described 
a novel approach to in vitro culturing of CEnC in which cell proliferation was accomplished by growth in a 
Source Term Name Term ID
FDR 
p-value
F99 Passage 0
GO:BP developmental process GO:0032502 4.2E-18
GO:BP system development GO:0048731 1.3E-16
GO:BP multicellular organism development GO:0007275 1.1E-15
GO:BP anatomical structure morphogenesis GO:0009653 3.6E-15
GO:BP tissue development GO:0009888 2.1E-14
GO:BP cellular developmental process GO:0048869 7.8E-14
GO:BP cell differentiation GO:0030154 2.3E-13
GO:BP cell development GO:0048468 3.6E-09
GO:BP tube development GO:0035295 3.8E-09
GO:BP blood vessel development GO:0001568 4.4E-09
GO:BP circulatory system development GO:0072359 4.6E-09
GO:BP regulation of cell differentiation GO:0045595 6.0E-09
GO:BP nervous system development GO:0007399 1.0E-07
GO:BP epithelium development GO:0060429 3.7E-07
KEGG TGF-beta signaling pathway KEGG:04350 3.2E-02
WP miR-509-3p alteration of YAP1/ECM axis WP:WP3967 5.1E-04
WP Epithelial to mesenchymal transition in colorectal cancer WP:WP4239 2.1E-02
WP Senescence and Autophagy in Cancer WP:WP615 3.2E-02
M5 Passage 0
GO:MF oxidoreductase activity GO:0016491 1.0E-18
GO:MF electron transfer activity GO:0009055 7.9E-16
GO:MF proton transmembrane transporter activity GO:0015078 1.3E-12
GO:MF cytochrome-c oxidase activity GO:0004129 2.3E-07
GO:MF NADH dehydrogenase activity GO:0003954 3.4E-07
GO:BP oxidative phosphorylation GO:0006119 4.9E-29
GO:BP cellular respiration GO:0045333 5.1E-25
GO:BP lipid oxidation GO:0034440 4.0E-05
GO:BP fatty acid oxidation GO:0019395 2.1E-04
GO:BP lipid catabolic process GO:0016042 9.2E-04
GO:BP fatty acid metabolic process GO:0006631 1.1E-03
GO:CC mitochondrial part GO:0044429 1.6E-47
GO:CC mitochondrion GO:0005739 3.8E-37
KEGG Oxidative phosphorylation KEGG:00190 1.5E-31
KEGG Citrate cycle (TCA cycle) KEGG:00020 7.0E-05
KEGG Fatty acid metabolism KEGG:01212 1.6E-03
WP
Electron Transport Chain 
(OXPHOS system in 
mitochondria)
WP:WP111 2.3E-38
WP Fatty Acid Beta Oxidation WP:WP143 2.2E-04
Table 1. Gene ontology and pathway enrichment analysis of the P0 inter-media comparison. Note: See Fig. S3A 
for complete set of inter-media comparisons. FDR, false discovery rate; GO, gene ontology; BP, biological 
process; MF, molecular function; CC, cellular component; KEGG, Kyoto encyclopedia of genes and genomes; 
WP, WikiPathways.
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Source Term Name Term ID
FDR 
p-value
F99 Passage 3
GO:BP system development GO:0048731 5.1E-06
GO:BP animal organ development GO:0048513 1.2E-05
GO:BP cellular response to stress GO:0033554 3.4E-04
GO:BP mitotic cell cycle GO:0000278 2.9E-03
GO:BP response to stress GO:0006950 3.6E-03
GO:BP regulation of mitotic cell cycle GO:0007346 1.4E-02
GO:BP cell differentiation GO:0030154 2.0E-02
GO:BP MAPK cascade GO:0000165 4.0E-02
GO:CC vesicle GO:0031982 6.3E-09
GO:CC endomembrane system GO:0012505 1.1E-08
KEGG p53 signaling pathway KEGG:04115 4.4E-04
KEGG Focal adhesion KEGG:04510 1.1E-02
KEGG Apelin signaling pathway KEGG:04371 3.3E-02
KEGG Cellular senescence KEGG:04218 4.8E-02
REAC Senescence-Associated Secretory Phenotype (SASP) REAC:R-HSA-2559582 3.0E-02
REAC Cell Cycle, Mitotic REAC:R-HSA-69278 4.2E-02
WP Wnt Signaling WP:WP428 1.1E-02
F99 Passage 4
GO:MF cyclin-dependent protein serine/threonine kinase inhibitor activity GO:0004861 3.6E-03
GO:BP nervous system development GO:0007399 1.0E-08
GO:BP response to oxidative stress GO:0006979 1.2E-07
GO:BP regulation of programmed cell death GO:0043067 7.1E-07
GO:BP apoptotic process GO:0006915 1.1E-06
GO:BP cell differentiation GO:0030154 2.2E-06
GO:BP mitotic cell cycle GO:0000278 1.3E-05
GO:BP aging GO:0007568 2.4E-02
GO:BP MAPK cascade GO:0000165 4.5E-02
GO:CC vesicle GO:0031982 1.8E-15
GO:CC endomembrane system GO:0012505 3.9E-15
KEGG Focal adhesion KEGG:04510 1.0E-06
KEGG p53 signaling pathway KEGG:04115 5.8E-05
KEGG Cellular senescence KEGG:04218 4.2E-03
KEGG PI3K-Akt signaling pathway KEGG:04151 8.5E-03
REAC Developmental Biology REAC:R-HSA-1266738 1.5E-02
REAC Cell Cycle, Mitotic REAC:R-HSA-69278 3.5E-02
M5 Passage 3
GO:MF growth factor binding GO:0019838 9.6E-04
GO:MF cyclin-dependent protein serine/threonine kinase regulator activity GO:0016538 3.2E-03
GO:BP cell cycle GO:0007049 1.7E-11
GO:BP regulation of programmed cell death GO:0043067 8.0E-07
GO:BP cell cycle phase transition GO:0044770 2.4E-06
GO:BP cell differentiation GO:0030154 2.0E-05
GO:BP programmed cell death GO:0012501 5.2E-05
GO:BP MAPK cascade GO:0000165 9.8E-05
GO:BP response to oxidative stress GO:0006979 2.1E-04
GO:BP aging GO:0007568 1.4E-02
GO:CC vesicle GO:0031982 2.2E-18
GO:CC endomembrane system GO:0012505 2.8E-08
KEGG Cell cycle KEGG:04110 2.9E-06
KEGG p53 signaling pathway KEGG:04115 1.1E-03
KEGG Focal adhesion KEGG:04510 1.6E-03
KEGG MAPK signaling pathway KEGG:04010 3.6E-03
REAC Cell Cycle, Mitotic REAC:R-HSA-69278 3.9E-06
Continued
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mitogenic-rich medium, followed by maintenance in a medium with reduced mitogens22. Coincidently, a recent 
report independently demonstrated the superiority of the dual media approach25. Taken together, these studies 
indicated that the low mitogenic medium established cultures with better morphology, marker expression and 
function compared with growth in a mitogen-rich medium alone. Herein, we compared the two culture meth-
ods published by Valtnik et al. and Peh et al. using extensive bioinformatics analyses and additional functional 
techniques to determine which method performs best in maintaining the CEnC phenotype throughout in vitro 
expansion.
Cell morphology is an initial metric for assessing the quality of CEnC cultures. We observed that the low 
mitogenic environment was better at maintaining a CEnC-like morphology, but continued passaging caused 
a distinct morphogenic transformation consistent with cellular senescence. This change in morphology corre-
lated with a progressive loss of CEnC identity as defined by the expression of evCEnC-specific genes. Temporal 
changes in evCEnC-specific gene expression as a consequence of passaging allowed us to identify a novel cell 
surface marker, encoded by TMEM178A, as a potential positive selection marker for high quality cultured CEnC. 
In addition, after a reassessment of reported selection markers, we propose SLC4A11 (positive), TMEM178A 
(positive) and CD44 (negative) as the minimum for selection of high quality in vitro CEnC25,26,30–35. SLC4A11 is 
a highly expressed transporter protein in the corneal endothelium that plays a significant role in CEnC function, 
and biallelic mutation of this protein leads to congenital hereditary endothelial dystrophy2,36,37. Conversely, CD44 
is not expressed in the corneal endothelium, and its expression correlates with a senescent phenotype in vascular 
and corneal endothelial cells38,39.
A prominent barrier to expansion of CEnC in vitro for use in a cell-based therapy is the limited proliferative 
capacity of primary CEnC. In vivo, CEnC are in a state of cellular quiescence, which in this cell type is specifically 
a cell cycle arrest at the G1 phase that is established by contact-inhibition, maintained by TGFβ2, and regulated 
by p27KIP140. However, in vivo CEnC have been shown to express senescent markers in older donors, which is 
postulated to contribute to the lower proliferative capacity of primary CEnC isolated from older donors compared 
with those from younger donors. Nevertheless, CEnC are able to re-engage the cell cycle by loosening of cell-cell 
contacts and/or exposure to potent mitogenic factors. As with most primary cells, primary CEnC have a limited 
life span under proliferative (i.e., passaging and growth in mitogen-rich) conditions. This limitation is caused 
by cellular senescence of CEnC (in vitro and ex vivo), and may be, in part, a consequence of oxidative stress41. 
This is supported by our observations in late passage CEnC (P3 and/or P4) that p38MAPK was phosphorylated 
(stress response), that expression of p16INK4 (gene and protein) was increased, and that the set of differentially 
expressed genes was enriched for genes implicated in oxidative stress-associated pathways (e.g., NRF2-mediated 
oxidative stress response, DNA damage checkpoint regulation). In addition, there is also an apparent repres-
sion of oxidative phosphorylation (i.e., mitochondrial activity), which was observed in our pathway analysis. 
Moreover, we also identified enrichment for genes associated with p53 signaling, an observation made previ-
ously18, and this coincided with phosphorylation of p53 and increased expression of p21CIP1 (CDKN1A) (gene 
and protein) in senescent CEnC (i.e., P3 and P4). Cell senescence in primary CEnC in this study was also asso-
ciated with increased expression of CDK4 and CDK6 proteins (but not gene expression), and increased cyclin 
Source Term Name Term ID
FDR 
p-value
M5 Passage 4
GO:MF cyclin-dependent protein serine/threonine kinase regulator activity GO:0016538 3.6E-02
GO:BP cell division GO:0051301 2.1E-09
GO:BP mitotic cell cycle GO:0000278 1.8E-08
GO:BP positive regulation of cell death GO:0010942 4.2E-08
GO:BP response to oxidative stress GO:0006979 5.3E-06
GO:BP cellular response to stress GO:0033554 7.3E-06
GO:BP regulation of MAPK cascade GO:0043408 6.8E-05
GO:BP electron transport chain GO:0022900 3.7E-04
GO:BP exocytosis GO:0006887 1.4E-03
GO:BP secretion by cell GO:0032940 5.8E-03
GO:CC vesicle GO:0031982 5.7E-21
KEGG Focal adhesion KEGG:04510 2.6E-05
KEGG MAPK signaling pathway KEGG:04010 1.0E-03
KEGG p53 signaling pathway KEGG:04115 1.5E-03
KEGG Oxidative phosphorylation KEGG:00190 3.8E-02
REAC The citric acid (TCA) cycle and respiratory electron transport REAC:R-HSA-1428517 2.2E-04
WP Electron Transport Chain (OXPHOS system in mitochondria) WP:WP111 6.3E-03
Table 2. Gene ontology and pathway enrichment analysis of the P3 and P4 intra-media comparisons. Note: 
Note: See Fig. S3B for complete set of intra-media comparisons. FDR, false discovery rate; GO, gene ontology; 
BP, biological process; MF, molecular function; CC, cellular component; KEGG, Kyoto encyclopedia of genes 
and genomes; REAC, REACTOME; WP, WikiPathways.
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Ingenuity Canonical Pathways z-score
F99 Passage 3
NRF2-mediated Oxidative Stress Response 3.36
IL-8 Signaling 2.89
Apelin Endothelial Signaling Pathway 2.71
Cell Cycle: G2/M DNA Damage Checkpoint 
Regulation 2.65
Chemokine Signaling 2.33
IL-3 Signaling 2.33
ERK/MAPK Signaling 1.90
VEGF Family Ligand-Receptor Interactions 1.89
IL-6 Signaling 1.89
IGF-1 Signaling 1.67
Acute Phase Response Signaling 1.67
JAK/Stat Signaling 1.41
p53 Signaling 1.13
FGF Signaling 1.00
Estrogen-mediated S-phase Entry −1.00
Cyclins and Cell Cycle Regulation −1.13
RhoGDI Signaling −1.41
LXR/RXR Activation −2.24
F99 Passage 4
Cell Cycle: G2/M DNA Damage Checkpoint 
Regulation 3.46
NRF2-mediated Oxidative Stress Response 3.27
IL-8 Signaling 3.09
Chemokine Signaling 2.89
p53 Signaling 2.83
UVC-Induced MAPK Signaling 2.33
IGF-1 Signaling 1.41
Inflammasome pathway 1.34
Apelin Endothelial Signaling Pathway 1.28
IL-6 Signaling 1.21
IL-1 Signaling 1.13
HGF Signaling 1.00
JAK/Stat Signaling 1.00
Estrogen-mediated S-phase Entry −1.13
Chondroitin Sulfate Degradation (Metazoa) −1.34
Pyrimidine Deoxyribonucleotides De Novo 
Biosynthesis I −1.34
NER Pathway −1.90
LXR/RXR Activation −3.00
M5 Passage 3
NRF2-mediated Oxidative Stress Response 3.27
Cell Cycle: G2/M DNA Damage Checkpoint 
Regulation 3.16
Chemokine Signaling 2.71
IL-8 Signaling 2.69
Acute Phase Response Signaling 2.50
IL-6 Signaling 2.32
TGF-β Signaling 2.11
Inflammasome pathway 2.00
IL-1 Signaling 1.89
JAK/Stat Signaling 1.51
p53 Signaling 1.39
p38 MAPK Signaling 1.00
Glycolysis I −1.00
Fatty Acid β-oxidation I −1.00
Estrogen Biosynthesis −1.00
Continued
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D (CCND1) gene expression. Taken together, this represents a gene/protein expression profile consistent with 
senescence-induced G1 cell cycle arrest. Overall, activation of the p38MAPK and p53 pathways did not appear 
significantly influenced by growth in a low- or high-mitogenic environment.
Achieving and maintaining characteristic CEnC functional properties is essential for the clinical utility of in 
vitro CEnC in management of CEnC dysfunction. The corneal endothelium is a monolayer mosaic of CEnC, and 
its primary function is to maintain the corneal stroma in a partially dehydrated state to preserve its optical clarity. 
It does this by establishing a robust barrier conferred by cell-cell and cell-substrate interactions, which allow for 
passive leak of water into the stroma, but not most solutes42. Through the combined action of various solute trans-
porters, unidirectional translocation of water from the stroma into the aqueous humor occurs43. Taken together, 
this describes the “pump-leak” hypothesis of water homeostasis in the cornea. We demonstrated that a low mito-
genic environment combined with culture on collagen represented better in vitro conditions for establishing 
a robust CEnC barrier (as measured by electrical impedance) compared with a high mitogenic environment 
and culture on laminin. In addition, our results prove that mitogen conditions have the greatest impact on bar-
rier function, while coating matrix and dissociation enzyme showed some and little impact on barrier function, 
respectively. Recent studies showed that collagen, compared with various other extracellular matrix proteins, 
including laminin, and low mitogen-containing media were optimal for establishing robust barrier function in a 
CEnC line44 and primary CEnC25. Detection of CDH2, a CEnC-specific marker, in CEnC cultures in low mito-
genic conditions demonstrated that cell adhesions (cell-cell and cell-substrate) are considerably more complex, 
and showed striking resemblance to the organization of adhesions in ex vivo human corneas45. We also demon-
strated that this increase in barrier function is associated with an increase in adhesion/glycocalyx-associated 
protein expression. To our knowledge, this represents the first report implicating glycocalyx proteins in cor-
neal endothelial biology. Although some of the barrier-associated proteins we examined in this study have been 
associated with the glycocalyx of the vascular endothelium46,47, it remains to be determined if the increase in 
glycocalyx-associated proteins coincides with the formation of a glycocalyx in corneal endothelium either in vitro 
or in vivo. However, early reports suggested that the human corneal endothelium may possess a glycocalyx-like 
layer composed of polysaccharides, glycosaminoglycans and other, as yet, unidentified molecules48–51. We also 
showed that at least two transporters critical for CEnC function (SLC4A4 and SLC4A11) are expressed at signif-
icantly higher levels and show increased transporter activity in low mitogenic conditions compared with high 
mitogenic conditions. As such, CEnC expanded in mitogenic-rich medium and maintained in low mitogenic 
conditions show functional features consistent with the CEnC requirement for regulating water homeostasis 
in the cornea. These results are consistent with previous studies demonstrating an intact pump function (i.e., 
prevention/mitigation of edema) in in vitro expanded corneal endothelial cells in an animal model of bullous 
keratopathy17,52.
Ingenuity Canonical Pathways z-score
Pyrimidine Deoxyribonucleotides De Novo 
Biosynthesis I −2.00
NER Pathway −2.33
LXR/RXR Activation −3.00
M5 Passage 4
NRF2-mediated Oxidative Stress Response 4.60
IL-8 Signaling 3.51
Chemokine Signaling 3.00
IL-6 Signaling 2.84
Cell Cycle: G2/M DNA Damage Checkpoint 
Regulation 2.67
Inflammasome pathway 2.24
p53 Signaling 2.07
IL-1 Signaling 1.90
Acute Phase Response Signaling 1.88
p38 MAPK Signaling 1.70
JAK/Stat Signaling 1.41
IGF-1 Signaling 1.34
Fatty Acid β-oxidation I −1.63
Acetyl-CoA Biosynthesis I (Pyruvate Dehydrogenase 
Complex) −2.00
Cholesterol Biosynthesis I −2.00
Superpathway of Cholesterol Biosynthesis −2.45
TCA Cycle II (Eukaryotic) −2.65
Oxidative Phosphorylation −5.11
Table 3. Activation state of Ingenuity canonical pathways in P3 and P4 intra-media comparisons. Notes: (1) See 
Fig. S3B for complete set of intra-media comparisons. (2) A positive z-score denotes activation and a negative 
z-score denotes deactivation.
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A long known characteristic of in vivo CEnC is that when mild cell loss occurs, the vacated area is covered 
by migration and increase in size of adjacent cells53. To determine if this phenomenon is recapitulated in vitro, 
we performed a non-wounding cell migration assay. Cells in a high mitogenic environment migrated and/or 
proliferated (not distinguished in our study) to cover the gap with no significant increase in cell size. In contrast, 
CEnC in low mitogenic conditions behaved in a manner consistent with their behavior in vivo, so that these cells 
showed low migration capacity, but a significant propensity to increase cell size to cover the gap. In addition, these 
results are consistent with the differences observed for cell barrier formation, because increased cell-cell adhesion 
is antithetical to robust cell migration (and also to robust cell proliferation capacity).
In summary, we provide evidence that CEnC proliferation in a high mitogenic medium, followed by main-
tenance of contact-inhibition of confluent monolayers in a low mitogenic medium, supports establishment of 
CEnC in which in vivo function is significantly recapitulated and permits sufficient expansion of CEnC to sig-
nificantly challenge the “one donor-one recipient” paradigm. In our current study, we can theoretically achieve a 
1:5–1:15 donor:recipient ratio (donor:recipient, 1:5 (P0) or 1:15 (P1) – at approximately 3000 cells/mm2), as these 
are the passages at which the cells possess the most robust CEnC phenotype as determined by gene (or marker) 
expression and cell morphology. Maintaining the CEnC morphologic and functional phenotype at higher passage 
numbers remains an active area of research. Also, while we examined cell function at an early passage (typically 
at P0), we recognize that functional analysis of cells will need to be performed at later passages to ensure viability 
as a therapeutic modality. The progression to senescence in vitro remains a significant barrier to the expansion 
of cultured CEnC. Identification of oxidative stress as a component of CEnC senescence has prompted inves-
tigators to add ascorbic acid as a supplement to early media formulations (added to F99 and M4) to reduce/
inhibit oxidant-induced stress/apoptosis54,55 and to use p38MAPK inhibitors to delay the onset of senescence, 
but this approach has shown mixed results18,56,57. In addition, senescent CEnC in vitro are characterized by the 
Senescence-Associated Secretory Phenotype (SASP), which includes the secretion of immune-regulating factors 
(cytokines, chemokines and growth factors) that have been demonstrated to support tumorigenesis in adjacent 
epithelial tissues58–61. As a remedy to senescence, we identify both classical and novel pathways associated with 
CEnC senescence that can be manipulated experimentally to potentially achieve significant CEnC expansion with 
minimal senescence. In addition, we identified which previously reported markers represent the optimal markers 
for selection of high quality cultured CEnC, and propose TMEM178A as a novel positive selection marker. We 
propose that because senescent CEnC can be present in cultured CEnC preparations and that senescent cells may 
Function Annotation z-score
F99 Passage 3
Senescence of cells 0.99
Replicative senescence of cells 0.60
Cell cycle progression −0.86
Re-entry into interphase −1.34
Mitosis −1.72
Initiation of interphase −1.73
F99 Passage 4
Senescence of tumor cell lines 1.51
G1 phase 1.35
Senescence of cells 0.69
M phase −0.53
M phase of cervical cancer cell lines −0.79
M phase of tumor cell lines −1.30
M5 Passage 3
Senescence of cells 1.14
G1 phase 0.90
Cell cycle progression −0.81
M phase −1.19
Mitosis −1.69
Segregation of chromosomes −2.13
M5 Passage 4
G1 phase 2.24
Senescence of cells 1.70
Cell cycle progression −0.88
Cytokinesis −1.06
M phase −1.18
Segregation of chromosomes −1.69
Table 4. Activation state of cell cycle functions in P0 and P4 intra-media comparisons. Notes: (1) See Fig. S3B 
for complete set of intra-media comparisons. (2) A positive z-score denotes activation and a negative z-score 
denotes deactivation.
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support tumorigenesis, a Descemet membrane biomimetic carrier is preferred to injection of a suspension of 
cells, to both maximize cell count and minimize their tumorigenic potential62–64. In conclusion, while additional 
changes to the dual media method may improve the culturing of CEnC in vitro, we provide evidence that this 
method is preferred to continuous culture in mitogen-rich media.
While the findings in our study represent a significant advance in the field of regenerative science, and specifi-
cally in the area of cell-based therapies to ameliorate corneal endothelial disease, our study has several limitations. 
The functional assays we performed (barrier, transport and migration) were performed in early passage cells (P0) 
comparing F99 with M5. In order to determine if the reduction of proteins important in CEnC function (e.g., 
SLC4A11) or increase of proteins associated with senescence represent a change detrimental to CEnC function, 
functional assays should be performed comparing early (P0, P1) with late (P3, P4) passage cells. Additionally, 
while the strength of our study is the comprehensive bioinformatics analyses that implicate many molecules 
and pathways, we did not validate novel pathways as part of this study, with the exception of the classic p53 and 
Figure 8. Cellular senescence of cultured CEnC is associated with activation of p53 and p38-MAPK pathways. 
(A) Bar graphs show TP53 and MAPK14 transcript levels in P0 and P3 CEnC using RNA-seq and validated by 
qPCR. Bar graphs show the quantification of TP53 and MAPK14 phosphorylation in P0 and P3 CEnC, and 
Western results show phosphorylation of TP53 at Serine 15 and MAPK14 at Threonine 180 and Tyrosine 182 
in CEnC at P0 and P3, cultured in either F99 or M5.(B) Bar graphs show the transcript abundances of LMNB1 
and GADD45A, and validated using qPCR. (C) Diagram of the cell cycle including factors that positively 
(cyclins and CDK) and negatively (INK4 and KIP/CIP) regulate cell cycle progression. (D,E) Bar graphs show: 
CDKN1A, CDKN2A, CDK4 and CDK6 transcript levels in P0 and P3 CEnC using RNA-seq and validated by 
qPCR; the quantification of the proteins encoded by these genes in P0 and P3 CEnC. The p21CIP1 (CDKN1A) 
and p16INK4 (CDKN2A) are inhibitors of cyclin-dependent kinases, and are classically associated with cellular 
senescence. Western results show increased expression of CDKN1A (p21CIP1) and CDKN2A (p16INK4) 
concomitant with increased expression of the CDK4 and CDK6 in CEnC at P3, cultured in either F99 or M5. 
(F) Line graphs show the transcript abundances of the cyclins at each passage in CEnC cultured in F99 or M5. 
TUBA was used as a loading control in the Westerns. Data in bar graphs are represented as the mean ± SEM 
(n = 7, RNA-seq; n = 4, qPCR; n = 3, Wes). Statistical comparisons were performed using one-way ANOVA 
with post-hoc Tukey test. *P < 0.05; **P < 0.01; ***P < 0.001.
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p38-MAPK pathways. To this end, this study forms the basis for researchers in regenerative medicine to use our 
findings to investigate novel interventions with the hope of delaying endothelial cell senescence and increasing 
expansion of cells for cell-based therapies.
Methods
Statement on the use of tissue from human subjects. Cadaveric corneal tissue was obtained from the 
Saving Sight eye bank and the Eversight network of eye banks in the United States (U.S.). Tissue that could not be 
placed for transplantation or that was deemed unsuitable for transplantation by eye bank medical staff was sub-
sequently made available for research purposes. Donor tissue procurement and processing adhered to the guide-
lines set by the Eye Bank Association of America, including obtaining informed consent, with oversight by the 
U.S. Food and Drug Administration. In addition, we attest that corneal tissue was not procured from prisoners.
primary corneal endothelial cell cultures. Characteristics of corneas used in this study are described in 
Supplementary Table S8 (14 donors, 28 corneas). Criteria used for selection of high quality donor corneal tissue 
were: (1) donor younger than 40 years (mean: 17.6; range: 2–35); (2) no donor history of diabetes or corneal dis-
ease; (3) endothelial cell density greater than 2300 cells/mm2 (mean: 3019; range: 2387–3436); (4) death to preser-
vation less than 12 hours, if body not cooled, or less than 24 hours, if body cooled; and 4) death to culture less than 
15 days (mean: 6; range: 2–14). Descemet membrane with attached endothelium was stripped from the stroma 
using the method commonly employed in preparation of the donor cornea for Descemet membrane endothelial 
keratoplasty. Seven independent CEnC cultures were established using two previously described protocols with 
minor modifications22,23. One method utilizes trypsin for dissociation of endothelial cells from Descemet mem-
brane, followed by seeding on laminin coated cell culture plastic, and culturing in a 1:1 mixture of F12-Ham’s and 
M199 (F99) medium (supplements: fetal bovine serum, human recombinant insulin, ascorbic acid, penicillin/
streptomycin, and recombinant human bFGF). The second method utilizes collagenase A for dissociation of 
endothelial cells from Descemet membrane. This is followed by seeding on collagen IV coated cell culture plas-
tic, and culturing initially in Endothelial SFM (M5) (supplements: fetal bovine serum, penicillin/streptomycin, 
and amphotericin-B) followed by culturing in a 1:1 mixture of F12-Ham’s and M199 (M4) medium (supple-
ments: fetal bovine serum, L-ascorbic acid-2-phosphate, penicillin/streptomycin, insulin-transferrin-selenium, 
amphotericin-B, and recombinant human bFGF). When cells reach confluence, the medium is changed back 
to M5 medium for establishment and maintenance of the CEnC phenotype. Cell passaging is performed with 
TrypLE Select (Thermo Fisher Scientific). Cells isolated using each protocol are referred to as F99 cells or M5 
(M4/M5 or dual media) cells to indicate the method used to establish the cultures. The specific corneas used for 
each of the seven cultures are noted in Supplementary Table S8. Two donors (2 pair of corneas) were used for each 
culture, with equal distribution of tissues so that each donor is represented in both the F99 and M5 conditions.
total RnA isolation. Primary CEnC were lysed in TRI Reagent (Thermo Fisher) and total RNA was pre-
pared as per the manufacturer’s instructions. RNA preparations were subsequently purified using the RNeasy 
Clean-Up Kit (Qiagen, Valencia, CA). The quality of the total RNA was assessed with both the Agilent 2100 
Electrophoresis Bioanalyzer System (Agilent Technologies, Inc., Santa Clara, CA) and the Agilent TapeStation 
2200 (Agilent Technologies, Inc.).
RnA-sequencing and data processing. RNA was isolated and RNA-seq libraries were prepared using 
the KAPA mRNA HyperPrep Kit with an automated liquid handler (Janus G3 – PerkinElmer) according to the 
manufacturer’s instructions. Library preparation was performed at the UCLA Institute for Quantitative and 
Computational Biology. DNA libraries were submitted to the UCLA Technology Center for Genomics and 
Bioinformatics for sequencing, which was performed on the Illumina HiSeq. 3000 platform. All RNA-seq data 
were single-end 50 base reads. Reads were aligned to the human GRCh38.p12 genome, and transcripts were 
quantified using the kallisto (v0.44.0) program65 with the Ensembl Annotation Release version 92. Quantities 
were given in transcripts per million (TPM), and differential gene expression analysis was performed with the 
Sleuth (v0.30.0) R-package66. Differential expression was tested using a likelihood ratio test (negative binomial 
test), and corrected for multiple testing using the Benjamini-Hochberg correction. Given the sporadic availa-
bility of donor corneas, each of the seven cultures was established as an individual batch. To account for batch 
effects in the data, we included batch number (i.e., culture number) as a covariate in the model used to test for 
differential expression. The following thresholds defined differential expression: fold change >1.5, TPM > 11.25 
and q-value < 0.05. Of note, our background threshold was 7.5 TPM, and thus the TPM threshold of 11.25 rep-
resents a 1.5 fold change increase above the background threshold. With the goal of achieving a balance between 
Type I and Type II errors, the background threshold was selected to retain genes with low expression (e.g., ZEB1 
with a TPM of ~25), but was sufficiently robust to exclude many genes with low (<7.5 TPM) abundance values. 
RNA-seq data generated from ex vivo corneal cell types were obtained from the GEO DataSets database (acces-
sion GSE121922). RNA-seq data generated for this study were submitted to GEO DataSets and assigned accession 
number GSE132204.
Gene ontology and pathway analysis. Gene ontology (GO) and pathway analysis on gene symbols 
only was performed using the web-based tool gProfiler (version: e94_eg41_p11_04285a3)67. The three main 
GO categories are Molecular Function (MF), Biological Process (BP) and Cellular Component (CC) (data ver-
sion: release/2018-12-28). Databases used for pathway analysis were Kyoto Encyclopedia of Genes and Genomes 
(KEGG) pathways (version: KEGG FTP Release 2019-01-07), REACTOME (REAC) pathways (classes: 2019-1-
24), and WikiPathways (WP)(version: 20190110). The g:SCS method for computing multiple testing correction 
was used for selecting significantly enriched GO terms and pathways identified by gProfiler. Ingenuity Pathway 
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Analysis software (Qiagen; build: 486617 M) was used to determine the pathways enriched and activated in our 
lists of differentially expressed genes.
Quantitative pcR. Quantitative polymerase chain reaction (qPCR) was performed to validate gene tran-
script abundances observed by RNA-seq. Total RNA (100 ng) was subjected to first-strand cDNA synthesis 
using the SuperScript III First-Strand Synthesis kit (Thermo Fisher Scientific) with oligo-dT primers. Reactions 
were performed on the LightCycler 480 System (Roche) using the KAPA SYBR FAST qPCR Kit (Roche) and 
gene-specific oligonucleotide primers obtained from the Harvard Primer Bank database68–70 or designed using 
the NCBI Primer-BLAST tool (Supplementary Table S9). Relative transcript abundances were calculated in com-
parison with the housekeeping gene RAB7 using the comparative Ct (2−∆Ct) method71. Transcript quantities were 
graphed as 2−∆Ct.
capillary-based, automated protein immunodetection assay. Cells were lysed with RIPA buffer 
and whole-cell lysates were prepared and processed for protein detection using the Wes separation 12–230 kDa 
capillary cartridges (Protein Simple). Separation and detection were performed as per the manufacturer’s instruc-
tions. Quantification and data analysis were performed using the Compass for SW software (version 3.1.7; build 
ID: 1205). Primary antibodies are listed in Supplementary Table S10. Uncropped Westerns are in Supplementary 
Information (Supplementary Figs. S4 and S5).
Morphometric analysis. At each passage, we acquired phase contrast images of confluent monolayers 
established in either F99 or M5. Image acquisition was performed with the Leica DMIL LED inverted microscope 
(Leica Microsystems), the N PLAN L 20×/0.35 PH1 objective, and the SPOT Insight color camera (Diagnostic 
Instruments, Inc.). Images were captured with the SPOT software (version 4.6). Image analysis was performed 
using ImageJ 1.51 h (National Institutes of Health). We created regions of interest (ROI) by outlining the periph-
ery of at least 20 representative cells using the freehand tool. ImageJ output the values for area (um2) and circu-
larity (ratio) for the selected ROI.
cell barrier assay. The electrode array 8W10E + ECIS (Applied BioPhysics) was stabilized with F99 or M5 
medium. The array surface was coated with 40 μg/cm2 chondroitin sulfate A (Sigma-Aldrich) and 400 ng/cm2 
laminin (Sigma-Aldrich) in phosphate-buffered saline (PBS) for two hours (for F99 cells) or with 7.5 μg/cm2 
collagen IV (Sigma-Aldrich) in 1x HEPES for 30 min (for M5 cells). Cells were seeded at a density to achieve 
100% confluence shortly after seeding, and were incubated in the arrays at room temperature for one hour to 
facilitate even distribution. After seeding and preliminary cell attachment, arrays were positioned into a 16-well 
array station and connected to the ECIS Zθ instrument to measure electric impedance (Ω at 4000 Hz) for 4 days. 
Cell-cell (Rb, Ω • cm2) and cell-substrate (α, Ω1/2 • cm) adhesion were modeled from the electric impedance data 
obtained at 4000 Hz72.
transporter assays. Lactate (SLC16A1), bicarbonate (SLC4A4) and proton (SLC4A11) transport were mon-
itored by measuring free H+ concentration (pHi) with a microscope fluorometer73 using the fluorescence-based 
(dual-excitation 500 nm and 440 nm) ratiometric pH indicator BCECF (Thermo Fisher Scientific), which was 
pre-loaded into the cells prior to substrate exposure.
SLC16A1 transporter. BCECF loading was performed in lactate-free solution (20 mM Na gluconate, 120 mM 
NaCl, 1 mM CaCl2, 1 mM MgCl2, 2.5 mM K2HPO4, 5 mM dextrose and 5 mM HEPES, pH 7.4). Fluorescence was 
monitored until a stable pHi was achieved. Subsequently, the lactate-free buffer was replaced by perfusion with 
lactate-containing solution (20 mM Na lactate in place of 20 mM Na gluoconate) for about 200 seconds and then 
switched back to the lactate-free solution.
SLC4A4 transporter. BCEFC loading was performed in bicarbonate-free solution (140 mM TMACl, 2.5 mM 
K2HPO4, 1 mM CaCl2, 1 mM MgCl2, 5 mM Dextrose and 5 mM HEPES, pH 7.4). After pHi stabilization was 
attained, the solution was replaced by perfusion with a solution containing tetramethylammonium bicarbonate 
(115 mM TMACl and 25 mM TMAHCO3 in place of 140 mM TMACl and 5 mM HEPES). Perfusion was per-
formed for about 200 seconds and then switched to a solution containing sodium bicarbonate (115 mM NaCl, 
2.5 mM K2HPO4, 1 mM CaCl2, 1 mM MgCl2, 5 mM Dextrose and 25 mM NaHCO3, pH 7.4), and fluorescence 
was monitored for an additional 400–600 seconds.
SLC4A11 transporter. BCECF loading was performed in HEPES buffer (110 mM KCl, 35 mM TMACl and 5 mM 
HEPES, pH 7.4). Once pHi stabilized, a second HEPES buffer (110 mM KCl, 35 mM TMACl and 5 mM HEPES 
pH 6.2) was replaced by perfusion and pHi was monitored for approximately 800 seconds.
cell migration assay. A non-wounding method to assess cell migration was used. Two-well silicone inserts 
(ibidi GmbH), each creating a 500um gap, were placed onto cell culture treated plastic. Wells were coated as 
described above for F99 and M5 cells. After cell isolation was performed, cells were seeded into each well and 
allowed to grow to confluence. Cell migration was initiated by removing the insert and was monitored for up to 
60 hours by phase-contrast microscopy. Images were acquired using the Leica DMIL LED inverted microscope 
(Leica Microsystems) and the N PLAN L 20×/0.35 PH1 objective. Image capture was performed with the Leica 
DFC3000 G monochrome camera controlled with the Leica Application Suite X software (version 3.0.3.16319). 
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Gap closure was measured at 22 hours and cell size was measured at 60 hours using ImageJ 1.51 h software 
(National Institutes of Health).
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